微创手术治疗良性前列腺梗阻的并发症发生率:现状如何?一项系统综述
该系统综述检索截至2024年1月的文献,最终纳入24项研究,评估Aquablation、蒸汽注射(Rezūm)、经会阴前列腺激光消融(TPLA)、前列腺尿道提升术(PUL)和临时植入式镍钛装置(iTIND)治疗良性前列腺梗阻所致下尿路症状的围术期及长期并发症。Aquablation主要并发症率为14%(IQR 6-22),PUL早期术后急性尿潴留率为10.9%(IQR 9.2-12.3%),iTIND主要围术期并发症率为1.4%。
要点
- Aquablation主要并发症率14%(IQR 6-22),尤其见于前列腺<70 ml患者。
- PUL早期术后急性尿潴留率10.9%(IQR 9.2-12.3%)。
- iTIND主要围术期并发症率1.4%;尿路感染主要见于TPLA和Rezūm系列。
核心结论
- 微创手术治疗良性前列腺增生所致下尿路症状与多样化的围术期和长期并发症相关,安全性可接受,特定并发症取决于所行微创手术类型,强调个体化患者选择和术式特异性考虑的重要性。
研究设计与样本
- 系统综述,检索Medline(via PubMed)、Embase(via Ovid)、Scopus和Web of Science,检索时间为2024年1月,采用PICO标准筛选,遵循PRISMA指南,评估偏倚风险和质量,初始检索得到3660条记录,最终24项研究符合纳入标准并纳入分析。
主要发现
- Aquablation主要并发症率为14%(IQR 6-22),尤其在前列腺<70 ml患者中。
- PUL早期术后急性尿潴留率为10.9%(IQR 9.2-12.3%)。
- iTIND主要围术期并发症率为1.4%。
- 尿路感染主要在评估TPLA和Rezūm的系列中报告。
关键数值与推荐
- Aquablation主要并发症率14%(IQR 6-22),尤其见于前列腺<70 ml患者。
- PUL早期术后急性尿潴留率10.9%(IQR 9.2-12.3%)。
- iTIND主要围术期并发症率1.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Over the past decade, the range of surgical options to benign prostatic obstruction (BPO) has expanded significantly with the advent of minimally invasive surgical therapies (MISTs). Nevertheless, the available evidence in the field is heterogeneous. Efficacy and safety thresholds are yet to be determined. OBJECTIVE: To evaluate perioperative and long-term complications after MISTs - including Aquablation, steam injection (Rezūm), Transperineal laser ablation of the prostate (TPLA), implantation of a prostatic urethral lift (PUL) and temporary implantable nitinol device (iTIND) - in patients with lower urinary tract symptoms due to BPO. EVIDENCE ACQUISITION: A systematic literature search was conducted in January 2024 using Medline (via PubMed), Embase (via Ovid), Scopus, and Web of Science. The search strategy used PICO criteria (Patients, Interventions, Comparisons, Outcomes) [1], focusing specifically on patients with BPH-associated LUTS who underwent MIST or other comparative treatments, aiming to assess both perioperative and long-term safety outcomes. Article selection was conducted in accordance with the PRISMA guidelines. The risk of bias and the quality of the articles included were assessed. A dedicated data extraction form was used to collect the data of interest. EVIDENCE SYNTHESIS: The initial electronic search identified 3660 records, of which 24 ultimately met the inclusion criteria and were included in the analysis. Overall, Aquablation was associated with a higher major complications rate of 14% (IQR 6-22), particularly in the case of patients with prostates <70 ml. PUL showed a higher early postoperative acute urinary retention rate (10.9%, IQR 9.2-12.3%), while 1.4% of patients treated with iTIND experienced major perioperative complications. Urinary tract infections were mostly reported in series assessing TPLA and Rezūm. CONCLUSIONS: The adoption of MISTs for LUTS due to BPH is associated with a varied spectrum of perioperative and long-term complications. Our findings showed an acceptable safety profile with specific complications dependent on the type of MIST performed, highlighting the importance of individualized patient selection and procedure-specific considerations.
引用
- Lambertini L, Sandulli A, Coco S, et al. Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature. Prostate Cancer Prostatic Dis. 2024. PMID: 39438691. doi:10.1038/s41391-024-00900-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。